IDEAYA Biosciences, Inc. announced that Daniel A. Simon, will join the company as its Chief Business Officer in August 2024. Mr. Simon most recently served as Chief Business Officer at Revolution Medicines from 2022 to 2024, and Senior Vice President, BioPharma Business Development at Guardant Health from 2015 to 2022. Prior to Guardant, he served in corporate development at Onyx Pharmaceuticals from 2012 to 2013, and as a consultant at McKinsey & Company in the London office from 2006 to 2012, working in the Pharmaceutical Practice.

Mr. Simon earned his MBA with honors from the Wharton School of the University of Pennsylvania, and his M.A. Hons in Natural Sciences from the University of Cambridge in the United Kingdom.